Andrew D. Krystal, MD
University of California, San Francisco
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Andrew D. Krystal, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:22 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT06580041 · Precision Care for Major Depressive DisorderUniversity of California, San Francisco · enrolling by invitation · Major Depressive Disorder, Depression, Depressive Disorder, Major · principal investigator
- Ph4NCT05463861 · Lemborexant in Delayed Sleep Phase SyndromeStanford University · recruiting · Delayed Sleep Phase Syndrome
- Ph1NCT02218775 · FASTMAS (Fast-Fail Trials in Mood and Anxiety Spectrum Disorders) Kappa Opioid Receptor Phase 1 StudyAndrew Krystal · withdrawn · Anxiety Disorders
- Ph4NCT00465972 · The Treatment of Insomnia in Patients With HIV DiseaseDuke University · completed · HIV Infections, Insomnia
- Ph4NCT00365976 · Study of the Insomnia in Patients With Low Back PainDuke University · completed · Primary Insomnia
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:22 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.